Showing results (1051-1060 of 1,240) with videos related to
Sort By:
Pageof 124
International Journal of Molecular Epidemiology and Genetics|October 17, 2017
Activation of the aryl hydrocarbon receptor and risk of lymphoma subtypesSonia Sanna, Giannina Satta, Marina Padoan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2018
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTShalini Shenoy, Javid Gaziev, Emanuele Angelucci, et al.Haematologica|May 10, 2007
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemiaOrietta Spinelli, Barbara Peruta, Manuela Tosi, et al.Stem Cells and Development|January 23, 2015
Molecular and phenotypic characterization of human amniotic fluid-derived cells: a morphological and proteomic approachCaterina Pipino, Laura Pierdomenico, Pamela Di Tomo, et al.Bone Marrow Transplantation|August 18, 2024
Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.Biomedicines|March 25, 2022
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of NeuroblastomaEnrico Rango, Fabio Pastorino, Chiara Brignole, et al.Journal of Neurology|May 21, 2022
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosisChristian Lunetta, Andrea Lizio, Corrado Cabona, et al.Journal of Medicinal Chemistry|December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastomaCristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.Infectious Diseases and Therapy|September 15, 2025
Antiviral Combination Treatment for COVID-19 in Immunocompromised Patients: Towards Defining Its Place in TherapyChiara Sepulcri, Claudia Bartalucci, Elisa Balletto, et al.British Journal of Haematology|January 15, 2016
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)Francesco Zallio, Stefania Tamiazzo, Chiara Monagheddu, et al.Pageof 124